Rocket Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript
The second day of the BOA Health Care Conference. My name is [Alister Murray]. I'm associate on the large biotechnology team here at Bank of America Merrill Lynch. I have the pleasure today of introducing Rocket Pharmaceuticals. From the company, we have Gaurav Shah, President and CEO of Rocket. Gaurav, I hand over to you.
Thanks for the introduction. It's good to see everyone. I will try to do about 10 or 12 minutes of going through slides pretty rapidly. Q&A is always my favorite part. So for those with questions, please ask them.
So Rocket Pharma -- how do I do this in 10 minutes relatively rapidly? Rocket Pharma started about 3.5 years ago, based out of New York City, with the idea that we wanted to address gene therapy through a multi-platform approach. So we're working with both in vivo AAV gene therapy and ex vivo lentiviral-based gene therapy. So we're multi-platform gene therapy company, and I think the essence of the philosophy here is that we want to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
